Skip Navigation Links
   
Skip Navigation Links
   

GI - Liver Cancer

GU - Liver Cancer Trials in St. Louis, MO


MATCH: Molecular analysis for therapy choice. Targeted therapy directed by genetic testing in treating patients with advanced refractory solid tumors or lymphoma.  EAY131 (NCT02465050)  (MBMC Contact: Henry Robinson 314-996-5865)

Randomized phase III study of focal rdiation therapy for unresectable localized intrahepatic cholangiocarinoma
 NRG GI001 NCT02200042 (MBMC Contact:  Henry Robinson 314-996-5865)

Randomized phase III study of sorafenib versus stereotactic body radiation therapy followed by sorafenib in hepatocellular carcinoma
(PENDING RT CREDENTIALING  NRG RTOG1112 (NCT01730936)  MBMC Contact: Henry Robinson 314-996-5865)

 
 
 

All contents 2007 Heartland Cancer Research St. Louis, MO. All rights reserved. Privacy Policy